Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022045

President and CEO sold 7,230 shares at $9.63 ($69,625)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2023-12-05 Sale −7,230 $9.63 $69,625 806,793 D
Open-market sales · 7,230 sh · avg $9.63 · $69,625
Loading xslF345X05/form4.xml…